Trial Profile
Safety, efficacy, pharmacokinetic and pharmacodynamic study of RCT-18 in Chinese patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2016
Price :
$35
*
At a glance
- Drugs Telitacicept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 09 Mar 2016 New trial record
- 25 Feb 2016 Results published in the British Journal of Clinical Pharmacology